JBCHEPHARM.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (13 May 2024 @ 05:59):

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally...

Stats
Today's Volume	74 519.00
Average Volume	163 993
Market Cap	278.30B
EPS	INR0 ( 2024-02-07 )
Next earnings date	( INR0 ) 2024-05-21
Last Dividend	INR9.25 ( 2023-08-16 )
Next Dividend	INR0 ( N/A )
P/E	55.12
ATR14	INR2.48 (0.14%)

Volume Correlation

Long: 0.16 (neutral)

Short: 0.57 (weak)

Signal:(61.7) Neutral

J. B. Chemicals & Correlation

10 Most Positive Correlations
ASIANHOTNR.NS	0.803

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

J. B. Chemicals & Correlation - Currency/Commodity

0.30
( neutral )

0.50
( neutral )

-0.32
( neutral )

-0.04
( neutral )

0.03
( neutral )

J. B. Chemicals & Financials

Annual	2022
Revenue:	INR31.49B
Gross Profit:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Revenue:	INR31.49B
Gross Profit:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Revenue:	INR24.24B
Gross Profit:	INR15.61B (64.39 %)
EPS:	INR49.86

FY	2021
Revenue:	INR20.06B
Gross Profit:	INR12.88B (64.23 %)
EPS:	INR57.96

Financial Reports:

No articles found.

J. B. Chemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR8.00 (N/A)	INR0 (N/A)	INR8.50 (N/A)	INR0 (N/A)	INR9.25 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

J. B. Chemicals & Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.86 - low (61.49%) | Divividend Growth Potential Score: 5.38 - Stable (7.51%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.600	2003-06-30
Last Dividend	INR9.25	2023-08-16
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR149.65	--
Avg. Dividend % Per Year	1.66%	--
Score	3.52	--
Div. Sustainability Score	4.86
Div.Growth Potential Score	5.38
Div. Directional Score	5.12	--

Next Divdend (Est)
(2024-12-10)

INR9.67 Estimate 6.79 %

Dividend Stability

0.27 Very Poor

Dividend Score

3.52

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.00	0.62%
2019	INR5.00	3.21%
2020	INR12.00	5.59%
2021	INR16.50	3.19%
2022	INR16.50	1.89%
2023	INR17.75	1.80%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SSWL.NS	Dividend Junior	2023-08-14	Annually	20	0.30%
MRF.NS	Dividend Knight	2023-07-20	Semi-Annually	23	0.11%
HEROMOTOCO.NS	Dividend Knight	2023-07-27	Semi-Annually	22	2.06%
BIOCON.NS	Dividend Junior	2023-07-06	Sporadic	21	0.18%
RECLTD.NS	Dividend King	2023-08-14	Quarterly	17	6.82%
KOTHARIPET.NS	Dividend Junior	2023-08-02	Annually	14	0.47%
ESTER.NS	Dividend Junior	2023-09-20	Sporadic	14	1.55%
ALPHAGEO.NS	Dividend Junior	2023-09-22	Annually	18	2.07%
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NGIL.NS	No Dividend Player	2023-09-21	Annually	4	0.08%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.198	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	59.22	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	14.16	2.00	2.92	5.84	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.890	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.855	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	54.12	1.000	4.63	0	[1 - 100]
returnOnEquityTTM	0.198	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	14.16	2.00	5.28	5.84	[0 - 30]
dividendYielPercentageTTM	0.564	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	8.59	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0648	1.000	-0.879	0	[0.1 - 0.5]
Total Score				5.38

J. B. Chemicals &

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.